Press releases | Medtronic

Month Year

Email alerts

Apr 1, 2010

Medtronic Commends U.S. Congress and President for Including National Pain Care Policy Act in Healthcare Reform Legislation to Address Barriers to and Solutions for Effective Pain Management

Company Teams with Physician and Patient Communities to Pass the National Pain Care Policy Act of 2009

MINNEAPOLIS, Apr 01, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) commended the U.S. Congress and President for signing H.R. 3590, the Patient Protection and Affordable Care Act legislation...
Apr 1, 2010

Medtronic to Appeal Jury Verdict in U.S. Patent Case Involving CoreValve(R) Transcatheter Aortic Valve System

MINNEAPOLIS, Apr 01, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), announced today that it will appeal the $73.5 million jury verdict returned in the U.S. District Court in Delaware deciding...
Mar 29, 2010

Medtronic and AGA Medical Settle Patent Dispute

MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), today announced the settlement of a lawsuit it initiated against AGA Medical Corp. in 2007 for infringement of Medtronic's...
Mar 29, 2010

Newly Published Data Show Medtronic InterStim(R) Therapy Decreases Episodes of Chronic Fecal Incontinence and Positively Impacts Quality of Life

InterStim Therapy for Bowel Control Currently Under Review by the U.S. FDA

MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim(R) Therapy...
Mar 23, 2010

First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity

Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4] Medtronic, Inc. (NYSE: MDT) today announced the enrollment...
Mar 19, 2010

Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI(TM) SureScan(TM) Pacing System

Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment

MINNEAPOLIS, Mar 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
Mar 18, 2010

First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia

MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
Mar 17, 2010

Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management

Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...
Mar 17, 2010

Medtronic Announces Next-Generation Pacing System for Use in MRI Machines Now Commercially Available in Selected European Geographies

Advisa DR MRI(TM) SureScan(TM) Represents the Most Advanced Pacing System from Medtronic that Combines MRI Compatibility with Exclusive Pacing Technology

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the commercial availability of the Advisa DR MRI(TM) SureScan(TM) pacemaker in selected European...
Mar 17, 2010

Medtronic Completes Pre-Market Approval Submission to FDA for Arctic Front(R) Cardiac CryoAblation Catheter System

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug...

Show per page